Pharma & Healthcare
Global Antibody-drug Conjugates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 223076
- Pages: 75
- Figures: 66
- Views: 42
The global Antibody-drug Conjugates market size was US$ 3102 million in 2024 and is forecast to a readjusted size of US$ 4258 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
The global Antibody-drug Conjugates market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ImmunoGen
Seattle Genetics
Roche
Takeda
By Type: (Dominant Segment vs High-Margin Innovation)
Adcetris
Kadcyla
By Application: (Core Demand Driver vs Emerging Opportunity)
Breast Cancer
Lymphoma
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ImmunoGen in Europe)
- Emerging Product Trends: Adcetris adoption vs. Kadcyla premiumization
- Demand-Side Dynamics: Breast Cancer growth in China vs. Lymphoma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antibody-drug Conjugates market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Kadcyla in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Lymphoma in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Adcetris dominance in Europe vs. Kadcyla demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
The global Antibody-drug Conjugates market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ImmunoGen
Seattle Genetics
Roche
Takeda
By Type: (Dominant Segment vs High-Margin Innovation)
Adcetris
Kadcyla
By Application: (Core Demand Driver vs Emerging Opportunity)
Breast Cancer
Lymphoma
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ImmunoGen in Europe)
- Emerging Product Trends: Adcetris adoption vs. Kadcyla premiumization
- Demand-Side Dynamics: Breast Cancer growth in China vs. Lymphoma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antibody-drug Conjugates market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Kadcyla in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Lymphoma in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Adcetris dominance in Europe vs. Kadcyla demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Antibody-drug Conjugates Product Scope
1.2 Antibody-drug Conjugates by Type
1.2.1 Global Antibody-drug Conjugates Sales by Type (2020 & 2024 & 2031)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Estimates and Forecasts (2020-2031)
1.4.1 Global Antibody-drug Conjugates Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Antibody-drug Conjugates Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Antibody-drug Conjugates Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Antibody-drug Conjugates Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Antibody-drug Conjugates Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Antibody-drug Conjugates Sales Market Share by Region (2020-2025)
2.2.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2020-2025)
2.3 Global Antibody-drug Conjugates Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Antibody-drug Conjugates Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Antibody-drug Conjugates Market Size and Prospective (2020-2031)
2.4.2 Europe Antibody-drug Conjugates Market Size and Prospective (2020-2031)
2.4.3 Japan Antibody-drug Conjugates Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Antibody-drug Conjugates Historic Market Review by Type (2020-2025)
3.1.1 Global Antibody-drug Conjugates Sales by Type (2020-2025)
3.1.2 Global Antibody-drug Conjugates Revenue by Type (2020-2025)
3.1.3 Global Antibody-drug Conjugates Price by Type (2020-2025)
3.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Antibody-drug Conjugates Sales Forecast by Type (2026-2031)
3.2.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2026-2031)
3.2.3 Global Antibody-drug Conjugates Price Forecast by Type (2026-2031)
3.3 Different Types Antibody-drug Conjugates Representative Players
4 Global Market Size by Application
4.1 Global Antibody-drug Conjugates Historic Market Review by Application (2020-2025)
4.1.1 Global Antibody-drug Conjugates Sales by Application (2020-2025)
4.1.2 Global Antibody-drug Conjugates Revenue by Application (2020-2025)
4.1.3 Global Antibody-drug Conjugates Price by Application (2020-2025)
4.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Antibody-drug Conjugates Sales Forecast by Application (2026-2031)
4.2.2 Global Antibody-drug Conjugates Revenue Forecast by Application (2026-2031)
4.2.3 Global Antibody-drug Conjugates Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Antibody-drug Conjugates Application
5 Competition Landscape by Players
5.1 Global Antibody-drug Conjugates Sales by Players (2020-2025)
5.2 Global Top Antibody-drug Conjugates Players by Revenue (2020-2025)
5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2024)
5.4 Global Antibody-drug Conjugates Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Antibody-drug Conjugates, Product Type & Application
5.7 Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antibody-drug Conjugates Sales by Company
6.1.1.1 North America Antibody-drug Conjugates Sales by Company (2020-2025)
6.1.1.2 North America Antibody-drug Conjugates Revenue by Company (2020-2025)
6.1.2 North America Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.1.3 North America Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.1.4 North America Antibody-drug Conjugates Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antibody-drug Conjugates Sales by Company
6.2.1.1 Europe Antibody-drug Conjugates Sales by Company (2020-2025)
6.2.1.2 Europe Antibody-drug Conjugates Revenue by Company (2020-2025)
6.2.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.2.3 Europe Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.2.4 Europe Antibody-drug Conjugates Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments, Downstream and Major Customers
6.3.1 Japan Antibody-drug Conjugates Sales by Company
6.3.1.1 Japan Antibody-drug Conjugates Sales by Company (2020-2025)
6.3.1.2 Japan Antibody-drug Conjugates Revenue by Company (2020-2025)
6.3.2 Japan Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.3.3 Japan Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.3.4 Japan Antibody-drug Conjugates Major Customer
6.3.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 ImmunoGen
7.1.1 ImmunoGen Company Information
7.1.2 ImmunoGen Business Overview
7.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
7.1.5 ImmunoGen Recent Development
7.2 Seattle Genetics
7.2.1 Seattle Genetics Company Information
7.2.2 Seattle Genetics Business Overview
7.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
7.2.5 Seattle Genetics Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Business Overview
7.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Roche Antibody-drug Conjugates Products Offered
7.3.5 Roche Recent Development
7.4 Takeda
7.4.1 Takeda Company Information
7.4.2 Takeda Business Overview
7.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Takeda Antibody-drug Conjugates Products Offered
7.4.5 Takeda Recent Development
8 Antibody-drug Conjugates Manufacturing Cost Analysis
8.1 Antibody-drug Conjugates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antibody-drug Conjugates
8.4 Antibody-drug Conjugates Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Antibody-drug Conjugates Distributors List
9.3 Antibody-drug Conjugates Customers
10 Antibody-drug Conjugates Market Dynamics
10.1 Antibody-drug Conjugates Industry Trends
10.2 Antibody-drug Conjugates Market Drivers
10.3 Antibody-drug Conjugates Market Challenges
10.4 Antibody-drug Conjugates Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Antibody-drug Conjugates Product Scope
1.2 Antibody-drug Conjugates by Type
1.2.1 Global Antibody-drug Conjugates Sales by Type (2020 & 2024 & 2031)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Estimates and Forecasts (2020-2031)
1.4.1 Global Antibody-drug Conjugates Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Antibody-drug Conjugates Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Antibody-drug Conjugates Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Antibody-drug Conjugates Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Antibody-drug Conjugates Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Antibody-drug Conjugates Sales Market Share by Region (2020-2025)
2.2.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2020-2025)
2.3 Global Antibody-drug Conjugates Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Antibody-drug Conjugates Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Antibody-drug Conjugates Market Size and Prospective (2020-2031)
2.4.2 Europe Antibody-drug Conjugates Market Size and Prospective (2020-2031)
2.4.3 Japan Antibody-drug Conjugates Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Antibody-drug Conjugates Historic Market Review by Type (2020-2025)
3.1.1 Global Antibody-drug Conjugates Sales by Type (2020-2025)
3.1.2 Global Antibody-drug Conjugates Revenue by Type (2020-2025)
3.1.3 Global Antibody-drug Conjugates Price by Type (2020-2025)
3.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Antibody-drug Conjugates Sales Forecast by Type (2026-2031)
3.2.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2026-2031)
3.2.3 Global Antibody-drug Conjugates Price Forecast by Type (2026-2031)
3.3 Different Types Antibody-drug Conjugates Representative Players
4 Global Market Size by Application
4.1 Global Antibody-drug Conjugates Historic Market Review by Application (2020-2025)
4.1.1 Global Antibody-drug Conjugates Sales by Application (2020-2025)
4.1.2 Global Antibody-drug Conjugates Revenue by Application (2020-2025)
4.1.3 Global Antibody-drug Conjugates Price by Application (2020-2025)
4.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Antibody-drug Conjugates Sales Forecast by Application (2026-2031)
4.2.2 Global Antibody-drug Conjugates Revenue Forecast by Application (2026-2031)
4.2.3 Global Antibody-drug Conjugates Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Antibody-drug Conjugates Application
5 Competition Landscape by Players
5.1 Global Antibody-drug Conjugates Sales by Players (2020-2025)
5.2 Global Top Antibody-drug Conjugates Players by Revenue (2020-2025)
5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2024)
5.4 Global Antibody-drug Conjugates Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Antibody-drug Conjugates, Product Type & Application
5.7 Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antibody-drug Conjugates Sales by Company
6.1.1.1 North America Antibody-drug Conjugates Sales by Company (2020-2025)
6.1.1.2 North America Antibody-drug Conjugates Revenue by Company (2020-2025)
6.1.2 North America Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.1.3 North America Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.1.4 North America Antibody-drug Conjugates Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antibody-drug Conjugates Sales by Company
6.2.1.1 Europe Antibody-drug Conjugates Sales by Company (2020-2025)
6.2.1.2 Europe Antibody-drug Conjugates Revenue by Company (2020-2025)
6.2.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.2.3 Europe Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.2.4 Europe Antibody-drug Conjugates Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments, Downstream and Major Customers
6.3.1 Japan Antibody-drug Conjugates Sales by Company
6.3.1.1 Japan Antibody-drug Conjugates Sales by Company (2020-2025)
6.3.1.2 Japan Antibody-drug Conjugates Revenue by Company (2020-2025)
6.3.2 Japan Antibody-drug Conjugates Sales Breakdown by Type (2020-2025)
6.3.3 Japan Antibody-drug Conjugates Sales Breakdown by Application (2020-2025)
6.3.4 Japan Antibody-drug Conjugates Major Customer
6.3.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 ImmunoGen
7.1.1 ImmunoGen Company Information
7.1.2 ImmunoGen Business Overview
7.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
7.1.5 ImmunoGen Recent Development
7.2 Seattle Genetics
7.2.1 Seattle Genetics Company Information
7.2.2 Seattle Genetics Business Overview
7.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
7.2.5 Seattle Genetics Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Business Overview
7.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Roche Antibody-drug Conjugates Products Offered
7.3.5 Roche Recent Development
7.4 Takeda
7.4.1 Takeda Company Information
7.4.2 Takeda Business Overview
7.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Takeda Antibody-drug Conjugates Products Offered
7.4.5 Takeda Recent Development
8 Antibody-drug Conjugates Manufacturing Cost Analysis
8.1 Antibody-drug Conjugates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antibody-drug Conjugates
8.4 Antibody-drug Conjugates Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Antibody-drug Conjugates Distributors List
9.3 Antibody-drug Conjugates Customers
10 Antibody-drug Conjugates Market Dynamics
10.1 Antibody-drug Conjugates Industry Trends
10.2 Antibody-drug Conjugates Market Drivers
10.3 Antibody-drug Conjugates Market Challenges
10.4 Antibody-drug Conjugates Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Antibody-drug Conjugates Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Antibody-drug Conjugates Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Antibody-drug Conjugates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antibody-drug Conjugates Sales (Kg) by Region (2020-2025)
Table 5. Global Antibody-drug Conjugates Sales Market Share by Region (2020-2025)
Table 6. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Antibody-drug Conjugates Revenue Share by Region (2020-2025)
Table 8. Global Antibody-drug Conjugates Sales (Kg) Forecast by Region (2026-2031)
Table 9. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Antibody-drug Conjugates Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Antibody-drug Conjugates Revenue Share Forecast by Region (2026-2031)
Table 12. Global Antibody-drug Conjugates Sales by Type (Kg) & (2020-2025)
Table 13. Global Antibody-drug Conjugates Sales Share by Type (2020-2025)
Table 14. Global Antibody-drug Conjugates Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Antibody-drug Conjugates Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Antibody-drug Conjugates Sales by Type (Kg) & (2026-2031)
Table 17. Global Antibody-drug Conjugates Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Antibody-drug Conjugates Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Antibody-drug Conjugates Sales by Application (Kg) & (2020-2025)
Table 21. Global Antibody-drug Conjugates Sales Share by Application (2020-2025)
Table 22. Global Antibody-drug Conjugates Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Antibody-drug Conjugates Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Antibody-drug Conjugates Sales by Application (Kg) & (2026-2031)
Table 25. Global Antibody-drug Conjugates Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Antibody-drug Conjugates Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Antibody-drug Conjugates Application
Table 28. Global Antibody-drug Conjugates Sales by Company (Kg) & (2020-2025)
Table 29. Global Antibody-drug Conjugates Sales Share by Company (2020-2025)
Table 30. Global Antibody-drug Conjugates Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Antibody-drug Conjugates Revenue Share by Company (2020-2025)
Table 32. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2024)
Table 33. Global Market Antibody-drug Conjugates Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Antibody-drug Conjugates, Product Type & Application
Table 36. Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 39. North America Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 40. North America Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 42. North America Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 43. North America Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 44. North America Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 45. North America Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 46. Europe Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 47. Europe Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 48. Europe Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 50. Europe Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 52. Europe Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 53. Europe Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 54. Japan Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 55. Japan Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 56. Japan Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 57. Japan Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 58. Japan Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 59. Japan Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 60. Japan Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 61. Japan Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 62. ImmunoGen Company Information
Table 63. ImmunoGen Description and Business Overview
Table 64. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. ImmunoGen Antibody-drug Conjugates Product
Table 66. ImmunoGen Recent Development
Table 67. Seattle Genetics Company Information
Table 68. Seattle Genetics Description and Business Overview
Table 69. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. Seattle Genetics Antibody-drug Conjugates Product
Table 71. Seattle Genetics Recent Development
Table 72. Roche Company Information
Table 73. Roche Description and Business Overview
Table 74. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Roche Antibody-drug Conjugates Product
Table 76. Roche Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Description and Business Overview
Table 79. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Takeda Antibody-drug Conjugates Product
Table 81. Takeda Recent Development
Table 82. Production Base and Market Concentration Rate of Raw Material
Table 83. Key Suppliers of Raw Materials
Table 84. Antibody-drug Conjugates Distributors List
Table 85. Antibody-drug Conjugates Customers List
Table 86. Antibody-drug Conjugates Market Trends
Table 87. Antibody-drug Conjugates Market Drivers
Table 88. Antibody-drug Conjugates Market Challenges
Table 89. Antibody-drug Conjugates Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Antibody-drug Conjugates Sales Market Share by Type in 2024 & 2031
Figure 4. Adcetris Product Picture
Figure 5. Kadcyla Product Picture
Figure 6. Global Antibody-drug Conjugates Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Antibody-drug Conjugates Sales Market Share by Application in 2024 & 2031
Figure 8. Breast Cancer Examples
Figure 9. Lymphoma Examples
Figure 10. Global Antibody-drug Conjugates Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Antibody-drug Conjugates Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 13. Global Antibody-drug Conjugates Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 14. Antibody-drug Conjugates Report Years Considered
Figure 15. Global Market Antibody-drug Conjugates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Antibody-drug Conjugates Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 19. Europe Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 21. Japan Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 23. Global Antibody-drug Conjugates Revenue Share by Type (2020-2025)
Figure 24. Global Antibody-drug Conjugates Sales Share by Type (2026-2031)
Figure 25. Global Antibody-drug Conjugates Revenue Share by Type (2026-2031)
Figure 26. Global Antibody-drug Conjugates Revenue Share by Application (2020-2025)
Figure 27. Global Antibody-drug Conjugates Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Antibody-drug Conjugates Sales Share by Application (2026-2031)
Figure 29. Global Antibody-drug Conjugates Revenue Share by Application (2026-2031)
Figure 30. Global Antibody-drug Conjugates Sales Share by Company (2024)
Figure 31. Global Antibody-drug Conjugates Revenue Share by Company (2024)
Figure 32. Global 5 Largest Antibody-drug Conjugates Players Market Share by Revenue in Antibody-drug Conjugates: 2020 & 2024
Figure 33. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Antibody-drug Conjugates
Figure 35. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 36. Antibody-drug Conjugates Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Table 1. Global Antibody-drug Conjugates Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Antibody-drug Conjugates Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Antibody-drug Conjugates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antibody-drug Conjugates Sales (Kg) by Region (2020-2025)
Table 5. Global Antibody-drug Conjugates Sales Market Share by Region (2020-2025)
Table 6. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Antibody-drug Conjugates Revenue Share by Region (2020-2025)
Table 8. Global Antibody-drug Conjugates Sales (Kg) Forecast by Region (2026-2031)
Table 9. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Antibody-drug Conjugates Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Antibody-drug Conjugates Revenue Share Forecast by Region (2026-2031)
Table 12. Global Antibody-drug Conjugates Sales by Type (Kg) & (2020-2025)
Table 13. Global Antibody-drug Conjugates Sales Share by Type (2020-2025)
Table 14. Global Antibody-drug Conjugates Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Antibody-drug Conjugates Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Antibody-drug Conjugates Sales by Type (Kg) & (2026-2031)
Table 17. Global Antibody-drug Conjugates Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Antibody-drug Conjugates Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Antibody-drug Conjugates Sales by Application (Kg) & (2020-2025)
Table 21. Global Antibody-drug Conjugates Sales Share by Application (2020-2025)
Table 22. Global Antibody-drug Conjugates Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Antibody-drug Conjugates Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Antibody-drug Conjugates Sales by Application (Kg) & (2026-2031)
Table 25. Global Antibody-drug Conjugates Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Antibody-drug Conjugates Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Antibody-drug Conjugates Application
Table 28. Global Antibody-drug Conjugates Sales by Company (Kg) & (2020-2025)
Table 29. Global Antibody-drug Conjugates Sales Share by Company (2020-2025)
Table 30. Global Antibody-drug Conjugates Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Antibody-drug Conjugates Revenue Share by Company (2020-2025)
Table 32. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2024)
Table 33. Global Market Antibody-drug Conjugates Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Antibody-drug Conjugates, Product Type & Application
Table 36. Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 39. North America Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 40. North America Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 42. North America Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 43. North America Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 44. North America Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 45. North America Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 46. Europe Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 47. Europe Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 48. Europe Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 50. Europe Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 52. Europe Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 53. Europe Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 54. Japan Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 55. Japan Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 56. Japan Antibody-drug Conjugates Revenue by Company (2020-2025) & (US$ Million)
Table 57. Japan Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 58. Japan Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 59. Japan Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 60. Japan Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 61. Japan Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 62. ImmunoGen Company Information
Table 63. ImmunoGen Description and Business Overview
Table 64. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. ImmunoGen Antibody-drug Conjugates Product
Table 66. ImmunoGen Recent Development
Table 67. Seattle Genetics Company Information
Table 68. Seattle Genetics Description and Business Overview
Table 69. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. Seattle Genetics Antibody-drug Conjugates Product
Table 71. Seattle Genetics Recent Development
Table 72. Roche Company Information
Table 73. Roche Description and Business Overview
Table 74. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Roche Antibody-drug Conjugates Product
Table 76. Roche Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Description and Business Overview
Table 79. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Takeda Antibody-drug Conjugates Product
Table 81. Takeda Recent Development
Table 82. Production Base and Market Concentration Rate of Raw Material
Table 83. Key Suppliers of Raw Materials
Table 84. Antibody-drug Conjugates Distributors List
Table 85. Antibody-drug Conjugates Customers List
Table 86. Antibody-drug Conjugates Market Trends
Table 87. Antibody-drug Conjugates Market Drivers
Table 88. Antibody-drug Conjugates Market Challenges
Table 89. Antibody-drug Conjugates Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Antibody-drug Conjugates Sales Market Share by Type in 2024 & 2031
Figure 4. Adcetris Product Picture
Figure 5. Kadcyla Product Picture
Figure 6. Global Antibody-drug Conjugates Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Antibody-drug Conjugates Sales Market Share by Application in 2024 & 2031
Figure 8. Breast Cancer Examples
Figure 9. Lymphoma Examples
Figure 10. Global Antibody-drug Conjugates Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Antibody-drug Conjugates Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 13. Global Antibody-drug Conjugates Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 14. Antibody-drug Conjugates Report Years Considered
Figure 15. Global Market Antibody-drug Conjugates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Antibody-drug Conjugates Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 19. Europe Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 21. Japan Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan Antibody-drug Conjugates Sales (Kg) Growth Rate (2020-2031)
Figure 23. Global Antibody-drug Conjugates Revenue Share by Type (2020-2025)
Figure 24. Global Antibody-drug Conjugates Sales Share by Type (2026-2031)
Figure 25. Global Antibody-drug Conjugates Revenue Share by Type (2026-2031)
Figure 26. Global Antibody-drug Conjugates Revenue Share by Application (2020-2025)
Figure 27. Global Antibody-drug Conjugates Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Antibody-drug Conjugates Sales Share by Application (2026-2031)
Figure 29. Global Antibody-drug Conjugates Revenue Share by Application (2026-2031)
Figure 30. Global Antibody-drug Conjugates Sales Share by Company (2024)
Figure 31. Global Antibody-drug Conjugates Revenue Share by Company (2024)
Figure 32. Global 5 Largest Antibody-drug Conjugates Players Market Share by Revenue in Antibody-drug Conjugates: 2020 & 2024
Figure 33. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Antibody-drug Conjugates
Figure 35. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 36. Antibody-drug Conjugates Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232